Insider Transactions Reported by 23 Insiders of iTeos Therapeutics, Inc.

Location
Watertown, MA

Insiders trading volume in the past year

iTeos Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
RA CAPITAL MANAGEMENT, L.P. Former 10% Owner $137,049,292 10 May 2024
EcoR1 Capital, LLC 10%+ Owner $85,511,824 +$38,685,562 +83% 14 May 2025
Boxer Capital, LLC Other* $51,571,013 10 May 2024
Ansbert Gadicke Former 10% Owner $27,829,543 -$8,317,364 -23% 13 May 2025
L.P. MPM BioVentures 2014 Former 10% Owner $16,995,267 -$5,079,339 -23% 13 May 2025
MPM BIOVENTURES 2018, L.P. Former 10% Owner $16,995,267 -$5,079,339 -23% 13 May 2025
Timothy Van Hauwermeiren Director $96,087 13 May 2025
Michel Detheux Chief Executive Officer, Director $0 -$2,640,784 -100% 29 Aug 2025
David Hallal Director $0 -$1,164,405 -100% 29 Aug 2025
David Feltquate Chief Medical Officer $0 29 Aug 2025
Yvonne McGrath Chief Scientific Officer $0 29 Aug 2025
Matthew Call Chief Operating Officer $0 29 Aug 2025
Matthew Gall Chief Financial Officer $0 29 Aug 2025
Detlev Biniszkiewicz Director 09 Jun 2022
Joanne Jenkins Lager Chief Medical Officer 09 Mar 2023
Jill DeSimone Director 11 Jun 2024
David K. Lee Director 29 Aug 2025
Derek DiRocco Director 13 Jun 2023
ANN D. RHOADS Director 29 Aug 2025
Davis Aaron I. Director 11 Jun 2024
Tony W. Ho Director 11 Jun 2024
Matthew Roden Director 09 Jun 2022
Robert Iannone Director 11 Jun 2024

Recent Insider Transactions by Companies or Individuals for iTeos Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.